Management of Nocturnal Acid Breakthrough on PPI Therapy

First-Line Approach: Add Bedtime H2RA

The American Gastroenterological Association recommends adding a bedtime H2-receptor antagonist (H2RA) to existing PPI regimen to control nocturnal acid breakthrough, as this combination is specifically effective for nighttime symptoms despite the limitation of H2RA tachyphylaxis 1, 2
Adding an H2RA at bedtime (ranitidine 150-300 mg or famotidine 20-40 mg) to current PPI therapy improves nighttime reflux in patients already on PPI therapy, though efficacy is limited by tachyphylaxis with frequent use 2, 3

The American College of Gastroenterology suggests considering alginate antacids for breakthrough nighttime symptoms, particularly if patients have post-prandial symptoms or a known hiatal hernia 1, 4
Alginates neutralize the post-prandial acid pocket and may be particularly useful for patients with nighttime symptoms 1, 4

Ensure proper PPI timing: dose should be taken 30-60 minutes before the first meal of the day, as recommended by the American Gastroenterological Association 6
Consider escalating to twice-daily PPI dosing (before breakfast and dinner) if not already on this regimen, as suggested by the American College of Gastroenterology 1, 4
Patients with long-segment Barrett's esophagus (>3 cm) have particularly high levels of nocturnal esophageal acid exposure and may require twice-daily PPI therapy, according to the American Society for Gastrointestinal Endoscopy 7

Be aware that H2RAs develop tachyphylaxis with frequent use, which limits their long-term effectiveness, as noted by the American College of Gastroenterology 1, 2

Verify PPI compliance and timing (30-60 minutes before first meal), as recommended by the American Gastroenterological Association 6
If on once-daily PPI: Escalate to twice-daily dosing (before breakfast and dinner), as suggested by the American College of Gastroenterology 1, 4
If already on twice-daily PPI or nocturnal symptoms persist: Add bedtime H2RA (ranitidine 150-300 mg or famotidine 20-40 mg), as recommended by the American Gastroenterological Association 2, 3
Consider adding alginate antacids for additional breakthrough symptom control, especially post-prandial and nighttime, as suggested by the American College of Gastroenterology 1, 4